Gilead Sciences, Inc. (GILD) Earnings History
Elite Compounder36 years of earnings data (1990–2025) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality
Loading earnings history...
Gilead Sciences, Inc. (GILD) Earnings Overview
As of June 22, 2026, Gilead Sciences, Inc. (GILD) reported trailing twelve-month net income of $9.22B, reflecting +1684.2% year-over-year growth. The company earned $7.35 per diluted share over the past four quarters, with a net profit margin of 28.9%.
Looking at the long-term picture, GILD's 5-year EPS compound annual growth rate (CAGR) stands at +133.6%, indicating exceptional earnings growth. The company achieved its highest annual net income of $18.11B in fiscal 2015.
Gilead Sciences, Inc. maintains industry-leading profitability with a gross margin of 78.8%, operating margin of 39.7%, and net margin of 28.9%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ABBV ($4.23B net income, 6.9% margin), BMY ($7.28B net income, 14.6% margin), AMGN ($7.80B net income, 21.0% margin), GILD has outperformed on profitability metrics. Compare GILD vs ABBV →
GILD Earnings vs Peers
Earnings metrics vs comparable public companies
GILD Historical Earnings Data (1990–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $8.51B | +1672.9% | $11.70B | $6.78 | 28.9% | 39.7% |
| 2024 | $480M | -91.5% | $1.66B | $0.38 | 1.7% | 5.8% |
| 2023 | $5.67B | +23.4% | $7.61B | $4.50 | 20.9% | 28.0% |
| 2022 | $4.59B | -26.2% | $7.33B | $3.64 | 16.8% | 26.9% |
| 2021 | $6.22B | +4961.0% | $9.92B | $4.93 | 22.8% | 36.3% |
| 2020 | $123M | -97.7% | $4.07B | $0.10 | 0.5% | 16.5% |
| 2019 | $5.39B | -1.3% | $4.29B | $4.22 | 24.0% | 19.1% |
| 2018 | $5.46B | +17.9% | $8.20B | $4.17 | 24.7% | 37.1% |
| 2017 | $4.63B | -65.7% | $14.12B | $3.51 | 17.7% | 54.1% |
| 2016 | $13.50B | -25.4% | $17.63B | $9.94 | 44.4% | 58.0% |
| 2015 | $18.11B | +49.6% | $22.19B | $11.91 | 55.5% | 68.0% |
| 2014 | $12.10B | +293.5% | $15.27B | $7.35 | 48.6% | 61.3% |
| 2013 | $3.08B | +18.6% | $4.52B | $1.81 | 27.5% | 40.4% |
| 2012 | $2.59B | -7.5% | $4.01B | $1.64 | 26.7% | 41.3% |
| 2011 | $2.80B | -3.4% | $3.79B | $1.78 | 33.4% | 45.2% |
| 2010 | $2.90B | +10.1% | $3.96B | $1.66 | 36.5% | 49.8% |
| 2009 | $2.64B | +33.2% | $3.53B | $1.41 | 37.6% | 50.3% |
| 2008 | $1.98B | +22.5% | $2.68B | $1.05 | 37.1% | 50.2% |
| 2007 | $1.62B | +235.7% | $2.16B | $0.84 | 38.2% | 51.2% |
| 2006 | -$1.19B | -246.2% | -$759M | $-0.65 | -39.3% | -25.1% |
| 2005 | $814M | +81.1% | $1.11B | $0.43 | 40.1% | 54.7% |
| 2004 | $449M | +724.1% | $627M | $0.25 | 33.9% | 47.4% |
| 2003 | -$72M | -199.9% | -$159M | $-0.04 | -8.3% | -18.3% |
| 2002 | $72M | +37.9% | $81M | $0.04 | 15.4% | 17.4% |
| 2001 | $52M | +192.1% | -$121M | $0.03 | 22.4% | -51.6% |
| 2000 | -$57M | +14.6% | -$52M | $-0.04 | -29.0% | -26.8% |
| 1999 | -$67M | -48.4% | -$52M | $-0.05 | -39.3% | -30.6% |
| 1998 | -$45M | +38.5% | -$78M | $-0.04 | -29.6% | -51.8% |
| 1997 | -$73M | -235.9% | -$72M | $-0.03 | -55.1% | -54.5% |
| 1996 | -$22M | +20.8% | -$36M | $-0.02 | -65.0% | -108.1% |
| 1995 | -$27M | +12.5% | -$32M | $-0.04 | -1014.8% | -1185.2% |
| 1994 | -$31M | -122.0% | -$35M | $-0.04 | -638.8% | -718.4% |
| 1992 | -$14M | -213.3% | -$18M | $-0.03 | -335.7% | -433.3% |
| 1991 | -$5M | -12.5% | -$6M | $-0.01 | -160.7% | -225.0% |
| 1990 | -$4M | - | -$5M | $-0.01 | -307.7% | -369.2% |
Download Data
Export GILD earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into GILD consensus models and risk factors.
Should I Buy GILD?
Wall Street verdict, signals, and target summaries.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
36+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GILD — Frequently Asked Questions
Quick answers to the most common questions about buying GILD stock.
What is GILD earnings per share (EPS)?
GILD trailing twelve-month (TTM) diluted EPS is $7.35, reflecting +1684.2% year-over-year growth. The 5-year EPS CAGR is +133.6%. Complete EPS history from 1990 to 2025 is available in the table on this page.
What is Gilead Sciences, Inc.'s net income?
Gilead Sciences, Inc. (GILD) trailing twelve-month net income is $9.2B as of 2025. Earnings grew +1684.2% year-over-year. Gilead Sciences, Inc. has been profitable for 19 consecutive years.
Is GILD profitable?
Yes, GILD is profitable with a TTM net income of $9.2B and a net profit margin of +28.9%. Gilead Sciences, Inc. has generated profits for 19 consecutive years.
What is GILD's earnings growth rate?
GILD compound annual EPS growth rates (CAGR): 1-Year: +1684.2%, 3-Year: +23.0%, 5-Year: +133.6%, 10-Year: -5.5%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1990 to 2025.
What are GILD's profit margins?
Gilead Sciences, Inc. net profit margin is +28.9%, operating margin is +39.7%, and gross margin is +78.8%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +40.7%.
Is GILD growing earnings?
Yes, GILD earnings are accelerating — EPS growth of +1684.2% exceeds the 5-year CAGR of +133.6%. TTM net income reached $9.2B. Earnings momentum is strengthening.
What was GILD's best earnings year?
Gilead Sciences, Inc.'s highest annual net income on record is $18.1B, achieved in fiscal year 2015. Earnings history on this page spans 1990 to 2025 and includes all annual and quarterly figures.
What were GILD's earnings last quarter?
GILD's most recent reported quarter was Q1 2026. Net income was $2.0B with diluted EPS of $1.61. For a full breakdown of all quarters, see the quarterly earnings table on this page.